Dosimetric predictors of temporal lobe injury after intensity-modulated radiotherapy for T4 nasopharyngeal carcinoma: a competing risk study

Abstract Background In patients with T4 nasopharyngeal carcinoma (NPC), death may occur prior to the occurrence of temporal lobe injury (TLI). Because such competing risk death precludes the occurrence of TLI and thus the competing risk analysis should be applied to TLI research. The aim was to inve...

Full description

Bibliographic Details
Main Authors: Juan Huang, Fang-fang Kong, Ronald Wihal Oei, Rui-ping Zhai, Chao-su Hu, Hong-mei Ying
Format: Article
Language:English
Published: BMC 2019-02-01
Series:Radiation Oncology
Online Access:http://link.springer.com/article/10.1186/s13014-019-1229-9
_version_ 1819065742520221696
author Juan Huang
Fang-fang Kong
Ronald Wihal Oei
Rui-ping Zhai
Chao-su Hu
Hong-mei Ying
author_facet Juan Huang
Fang-fang Kong
Ronald Wihal Oei
Rui-ping Zhai
Chao-su Hu
Hong-mei Ying
author_sort Juan Huang
collection DOAJ
description Abstract Background In patients with T4 nasopharyngeal carcinoma (NPC), death may occur prior to the occurrence of temporal lobe injury (TLI). Because such competing risk death precludes the occurrence of TLI and thus the competing risk analysis should be applied to TLI research. The aim was to investigate the incidence and predictive factors of TLI after intensity-modulated radiotherapy (IMRT) among T4 NPC patients. Methods From March 2008 to December 2014, T4 NPC patients treated with full-course radical IMRT at our center were reviewed retrospectively. A nested case-control study was designed for this cohort of patients. The cases were patients with TLI diagnosed by MRI during the follow-up period, and the controls were patients without TLI after IMRT matched 1:1 to each case by gender, age at diagnosis, intercranial involvement, and follow-up time. The end point was time to TLI or death without prior TLI. We analyzed the cumulative incidence function (CIF) and performed a competing risk regression model to identify the predictors of TLI. Results With a median follow-up of 40.1 months, 63 patients (63/506, 12.5%) developed TLI as diagnosed by MRI, and 136 deaths occurred during the period. The cumulative incidence of TLI at 5 years was 13.2%, while 26.7% died without prior TLI. The univariate analysis showed that all selected dosimetric parameters were associated with the occurrence of TLI. On multivariate analysis, D1cc and V20 remained statistically significant. Based on the area-under-the-curve (AUC) values, D1cc was considered the most predictive. The patients with D1cc > 71.14 Gy had a 7.920-fold increased risk of TLI compared with those with D1cc ≤71.14 Gy (P < 0.05). Similarly, V20 > 42.22 cc was found to result in a statistically significant higher risk of TLI (subdistribution hazard ratio [sHR] =3.123, P < 0.05). Conclusions TL D1cc and V20 were predictive of TLI after IMRT for T4 NPC. They should be considered as first and second priorities of dose constraints of the TL. D1cc ≤71.14 Gy and V20 ≤ 42.22 cc could be useful dose-volume constraints for reducing the occurrence of TLI during IMRT treatment planning without obviously compromising the tumor coverage.
first_indexed 2024-12-21T15:51:18Z
format Article
id doaj.art-e897b1e03ab24d369cfa45c1f6ef9897
institution Directory Open Access Journal
issn 1748-717X
language English
last_indexed 2024-12-21T15:51:18Z
publishDate 2019-02-01
publisher BMC
record_format Article
series Radiation Oncology
spelling doaj.art-e897b1e03ab24d369cfa45c1f6ef98972022-12-21T18:58:13ZengBMCRadiation Oncology1748-717X2019-02-0114111110.1186/s13014-019-1229-9Dosimetric predictors of temporal lobe injury after intensity-modulated radiotherapy for T4 nasopharyngeal carcinoma: a competing risk studyJuan Huang0Fang-fang Kong1Ronald Wihal Oei2Rui-ping Zhai3Chao-su Hu4Hong-mei Ying5Department of Radiation Oncology, Fudan University Shanghai Cancer CenterDepartment of Radiation Oncology, Fudan University Shanghai Cancer CenterDepartment of Radiation Oncology, Fudan University Shanghai Cancer CenterDepartment of Radiation Oncology, Fudan University Shanghai Cancer CenterDepartment of Radiation Oncology, Fudan University Shanghai Cancer CenterDepartment of Radiation Oncology, Fudan University Shanghai Cancer CenterAbstract Background In patients with T4 nasopharyngeal carcinoma (NPC), death may occur prior to the occurrence of temporal lobe injury (TLI). Because such competing risk death precludes the occurrence of TLI and thus the competing risk analysis should be applied to TLI research. The aim was to investigate the incidence and predictive factors of TLI after intensity-modulated radiotherapy (IMRT) among T4 NPC patients. Methods From March 2008 to December 2014, T4 NPC patients treated with full-course radical IMRT at our center were reviewed retrospectively. A nested case-control study was designed for this cohort of patients. The cases were patients with TLI diagnosed by MRI during the follow-up period, and the controls were patients without TLI after IMRT matched 1:1 to each case by gender, age at diagnosis, intercranial involvement, and follow-up time. The end point was time to TLI or death without prior TLI. We analyzed the cumulative incidence function (CIF) and performed a competing risk regression model to identify the predictors of TLI. Results With a median follow-up of 40.1 months, 63 patients (63/506, 12.5%) developed TLI as diagnosed by MRI, and 136 deaths occurred during the period. The cumulative incidence of TLI at 5 years was 13.2%, while 26.7% died without prior TLI. The univariate analysis showed that all selected dosimetric parameters were associated with the occurrence of TLI. On multivariate analysis, D1cc and V20 remained statistically significant. Based on the area-under-the-curve (AUC) values, D1cc was considered the most predictive. The patients with D1cc > 71.14 Gy had a 7.920-fold increased risk of TLI compared with those with D1cc ≤71.14 Gy (P < 0.05). Similarly, V20 > 42.22 cc was found to result in a statistically significant higher risk of TLI (subdistribution hazard ratio [sHR] =3.123, P < 0.05). Conclusions TL D1cc and V20 were predictive of TLI after IMRT for T4 NPC. They should be considered as first and second priorities of dose constraints of the TL. D1cc ≤71.14 Gy and V20 ≤ 42.22 cc could be useful dose-volume constraints for reducing the occurrence of TLI during IMRT treatment planning without obviously compromising the tumor coverage.http://link.springer.com/article/10.1186/s13014-019-1229-9
spellingShingle Juan Huang
Fang-fang Kong
Ronald Wihal Oei
Rui-ping Zhai
Chao-su Hu
Hong-mei Ying
Dosimetric predictors of temporal lobe injury after intensity-modulated radiotherapy for T4 nasopharyngeal carcinoma: a competing risk study
Radiation Oncology
title Dosimetric predictors of temporal lobe injury after intensity-modulated radiotherapy for T4 nasopharyngeal carcinoma: a competing risk study
title_full Dosimetric predictors of temporal lobe injury after intensity-modulated radiotherapy for T4 nasopharyngeal carcinoma: a competing risk study
title_fullStr Dosimetric predictors of temporal lobe injury after intensity-modulated radiotherapy for T4 nasopharyngeal carcinoma: a competing risk study
title_full_unstemmed Dosimetric predictors of temporal lobe injury after intensity-modulated radiotherapy for T4 nasopharyngeal carcinoma: a competing risk study
title_short Dosimetric predictors of temporal lobe injury after intensity-modulated radiotherapy for T4 nasopharyngeal carcinoma: a competing risk study
title_sort dosimetric predictors of temporal lobe injury after intensity modulated radiotherapy for t4 nasopharyngeal carcinoma a competing risk study
url http://link.springer.com/article/10.1186/s13014-019-1229-9
work_keys_str_mv AT juanhuang dosimetricpredictorsoftemporallobeinjuryafterintensitymodulatedradiotherapyfort4nasopharyngealcarcinomaacompetingriskstudy
AT fangfangkong dosimetricpredictorsoftemporallobeinjuryafterintensitymodulatedradiotherapyfort4nasopharyngealcarcinomaacompetingriskstudy
AT ronaldwihaloei dosimetricpredictorsoftemporallobeinjuryafterintensitymodulatedradiotherapyfort4nasopharyngealcarcinomaacompetingriskstudy
AT ruipingzhai dosimetricpredictorsoftemporallobeinjuryafterintensitymodulatedradiotherapyfort4nasopharyngealcarcinomaacompetingriskstudy
AT chaosuhu dosimetricpredictorsoftemporallobeinjuryafterintensitymodulatedradiotherapyfort4nasopharyngealcarcinomaacompetingriskstudy
AT hongmeiying dosimetricpredictorsoftemporallobeinjuryafterintensitymodulatedradiotherapyfort4nasopharyngealcarcinomaacompetingriskstudy